MacroGenics | Spese Operative



Operating Expenses Cambiamento Data
AbbVie USD 9.61B 6.98B 2025-03
Amgen USD 6.86B 85M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Biogen USD 2.12B 106.5M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Daiichi Sankyo JPY 435.08B 11.65B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Genmab DKK 4.25B 812M 2024-12
Geron USD 56.31M 12.99M 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
J&J USD 8.26B 10.37B 2025-03
MacroGenics USD 35.94M 20.58M 2024-12
Merck USD 9.66B 1.67B 2025-03
Pfizer USD 10.05B 8.12B 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Xencor USD 65.97M 7.02M 2024-12



MacroGenics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.